tradingkey.logo

Tactile Systems Technology Inc

TCMD
View Detailed Chart
27.910USD
+0.700+2.57%
Close 02/06, 16:00ETQuotes delayed by 15 min
623.39MMarket Cap
36.10P/E TTM

Tactile Systems Technology Inc

27.910
+0.700+2.57%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.57%

5 Days

-3.29%

1 Month

-8.49%

6 Months

+132.20%

Year to Date

-3.76%

1 Year

+62.55%

View Detailed Chart

Key Insights

Tactile Systems Technology Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 15 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 29.75.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tactile Systems Technology Inc's Score

Industry at a Glance

Industry Ranking
15 / 205
Overall Ranking
88 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Tactile Systems Technology Inc Highlights

StrengthsRisks
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 18.72% year-on-year.
Overvalued
The company’s latest PE is 36.10, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 22.52M shares, decreasing 19.92% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 37.65K shares of this stock.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
20.500
Target Price
+55.07%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Tactile Systems Technology Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Tactile Systems Technology Inc Info

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
Ticker SymbolTCMD
CompanyTactile Systems Technology Inc
CEODodd (Sheri L)
Websitehttps://www.tactilemedical.com/
KeyAI